Invention Grant
- Patent Title: Crystalline 4′-epidaunorubicin hydrochloride and use thereof
- Patent Title (中): 结晶4'-表柔皮霉素盐酸盐及其用途
-
Application No.: US14459850Application Date: 2014-08-14
-
Publication No.: US09434756B2Publication Date: 2016-09-06
- Inventor: Tero Kunnari , Holger Bindernagel , Sascha Weiser , Andrew Lupton , Stefan Wallert
- Applicant: Heraeus Precious Metals GmbH & Co. KG
- Applicant Address: DE Wedel
- Assignee: medac Gesellschaft für klinische Spezialpräparate mbH
- Current Assignee: medac Gesellschaft für klinische Spezialpräparate mbH
- Current Assignee Address: DE Wedel
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Priority: EP09011459 20090908
- Main IPC: C07H15/24
- IPC: C07H15/24 ; C07H15/252 ; C07H1/00

Abstract:
4′-epidaunorubicin hydrochloride is provided in a crystalline form which is stable and readily soluble. A process of producing the crystalline form includes crystallizing 4′-epidaunorubicin hydrochloride in a solvent system including (a) solvent A selected from C1 and C2 halogenated solvents and mixtures thereof, (b) solvent B selected from C1-C5 straight and branched alcohols and mixtures thereof, and (c) solvent C selected from C1-C5 straight and branched alcohols and mixtures thereof, wherein solvent C is selected to provide lower solubility to 4′-epidaunorubicin hydrochloride than solvent B. A method of producing an anthracycline using crystalline 4′-epidaunorubicin hydrochloride is also provided.
Public/Granted literature
- US20140357848A1 CRYSTALLINE 4'-EPIDAUNORUBICIN HYDROCHLORIDE AND USE THEREOF Public/Granted day:2014-12-04
Information query